About
Generative AI Platform for Biological Engineering
Converge Bio is aiming is revolutionize biological R&D by creating a Generative AI platform for DNA, RNA, and protein sequences.
Identity
| Name | Converge Bio |
|---|---|
| Slug | converge-bio |
| Type / kind | startup |
| Source _id | iJVV7JpteQTx2QdV2dKnONkyuwSGDQpJxkQsBE82ekVsmGkN7Or0is |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Daniel Frisch St, Tel Aviv-Yafo, Israel |
Web & social
| Website | https://converge-bio.com |
|---|---|
| https://www.linkedin.com/company/102539353 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical Biotechnology
Technologies
Artificial IntelligenceGenerative AI
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business models
B2B
Tags
pharmaceuticalsbiotechnologymolecular-biologyproteins
Funding
| Total raised | $30.5M |
|---|---|
| Current stage | Series A |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}